PLEASANTON, Calif., March 22, 2018 -- Co-founder and CEO of Title21 Health Solutions (www.Title21.com) Lynn Fischer will share her purpose-driven career story on The MENTORS RADIO SHOW this weekend. Listeners can hear the interview live on KTRB AM860 San Francisco at 7am PT on Saturday, March 24 and at noon on Sunday, March 25; and KCBQ AM1170 San Diego at 12pm PT Saturday, March 24; and on-demand anytime on TheMentorsRadio.com. Title21 Health Solutions is an innovative technology company in the San Francisco Bay Area that delivers integrated, easy-to-use Cloud Enterprise Quality Management Systems and end-to-end software that digitizes cell and gene manufacturing and bone marrow transplant programs.
Hosted by Mentor Tom Loarie, Ms. Fischer tells her story of pivoting a successful consumer packaged goods Marketing career with Gallo Winery, Dreyer’s Grand Ice Cream, M&M/Mars and The Wine Group to lead a patient-centric healthcare technology company. Lynn discusses how her passion to make a difference and improve patient quality and outcomes were the motivating factors to make the move to healthcare. “At the age of fifteen my Dad and mentor was diagnosed with melanoma, and Memorial Sloan Kettering Cancer Center saved his life. That experience had a profound impact on my desire to support the advancement of innovative, curative therapies through technology.”
Host, Tom Loarie stated, “Anyone considering a major career pivot will be inspired by Lynn’s story which reminds us that anything is possible when you allow your purpose and passion to steer your career journey.”
Ms. Fischer remarks, “I hope my career story will inspire others to lead with their heart and pursue a career that serves others even if it requires a pivot. Wine to healthcare technology was a big jump. If I can do it, anyone can.”
About Title21 Health Solutions
Title21 Health Solutions continues to gain national recognition for its innovative technology to help hospitals, biotechnology, regenerative medicine and other health science organizations improve quality, efficiency and patient safety. Title21’s product line includes web-based quality management solutions and the first end-to-end cell and gene therapy software available in the market. Learn more about Title21 and rewarding careers at www.Title21.com.
Media Contact Haley Roebuck [email protected]


Trump Urges Exxon, Chevron to Cut Gas Prices After Record Oil Profits
Siemens Energy Q3 Profit Beats Forecast as AI-Driven Power Demand Fuels Growth
Vast Eyes Hong Kong IPO as Chinese AI Unicorn Gains Momentum
DBS Raises 2025 Outlook After Record Q2 Profit Driven by Wealth Management
Apple Restores Telegram to App Store After Content Policy Violation
UK AI Security Tests Reveal Anthropic and OpenAI Agents Attempted Unauthorized Actions
DeepSeek to Raise AI API Prices as Demand for New Models Surges
SanDisk Q4 Earnings Beat Estimates as Q1 Revenue Outlook Meets Expectations
Samsung, SK Hynix Test AMEC Chipmaking Tools for China Backup Plan
Toyota Raises FY2027 Outlook, Announces ¥1 Trillion Buyback Despite Q1 Profit Dip
Bayer Q2 Earnings Beat Forecasts as Crop Science Boosts Results, Debt Outlook Improves
Palantir Stock Soars as AI Demand Drives Strong Q2 Earnings and Higher 2026 Outlook
DHL Q2 Profit Jumps 24% as Express Business Drives Growth
DoorDash Q2 Revenue Jumps 36% as Orders and DashPass Growth Drive Results
Jetstar to Charge for Overhead Cabin Bags From February
Glencore Posts Strong H1 2026 Earnings, Announces ASX Secondary Listing
BHP Port Hedland Strike Set to Proceed as Wage Talks Continue 



